✦ LIBER ✦

Obesity and metabolic syndrome: Future therapeutics based on novel molecular pathways

✍ Scribed by Gabriela Gutiérrez-Salmeán; Guillermo Ceballos-Reyes; Israel Ramírez-Sánchez

Book ID: 118416637
Publisher: Elsevier Science
Year: 2012
Tongue: Spanish
Weight: 331 KB
Volume: 24
Category: Article
ISSN: 1578-1879
DOI: 10.1016/j.arteri.2011.11.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The HIV-1/HAART associated metabolic syn

The HIV-1/HAART associated metabolic syndrome – Novel adipokines, molecular associations and therapeutic implications

✍ S. Tsiodras; A. Perelas; C. Wanke; C.S. Mantzoros 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 299 KB

ChemInform Abstract: Novel Therapeutic A

ChemInform Abstract: Novel Therapeutic Approach Based on Recent Understanding of the Development of Metabolic Syndrome

✍ Toru Hosoi 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 18 KB 👁 1 views

Nutritional and Therapeutic Intervention

Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome || The Effects of Resveratrol on Diabetes and Obesity

✍ Sanchez, Juan A. 📂 Article 📅 2012 🏛 Elsevier ⚖ 331 KB

Effects of natural S -equol supplements

Effects of natural S -equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status

✍ Usui, Takeshi; Tochiya, Mayu; Sasaki, Yousuke; Muranaka, Kazuya; Yamakage, Hajim 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

Obesity and metabolic syndrome are relat

Obesity and metabolic syndrome are related to low health-related quality of life in US adolescents based on national data

✍ Xiaoli Chen; Youfa Wang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A novel screening model for the molecula

A novel screening model for the molecular drug for diabetes and obesity based on tyrosine phosphatase Shp2

✍ Yanyan Bu; Tao Shi; Minghui Meng; Guiping Kong; Yingpu Tian; Quancheng Chen; Xin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 753 KB

Tyrosine phosphatase Src-homology phosphotyrosyl phosphatase 2 (Shp2) was identified as a potential molecular target for therapeutic treatment of diabetes and obesity. However, there is still no systematic research on the enhancers for the Shp2 enzyme. The present study established a novel powerful